Charter Research & Investment Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$551K Hold
6,007
– – 0.33% 59
2026
Q1
$512K Buy
6,007
+400
+7% +$35.6K 0.34% 57
2025
Q4
$443K Sell
5,607
-800
-12% -$62.7K 0.3% 62
2025
Q3
$512K Hold
6,407
– – 0.35% 56
2025
Q2
$582K Hold
6,407
– – 0.43% 51
2025
Q1
$600K Hold
6,407
– – 0.46% 54
2024
Q4
$582K Sell
6,407
-229
-3% -$21.9K 0.44% 53
2024
Q3
$689K Hold
6,636
– – 0.51% 46
2024
Q2
$644K Hold
6,636
– – 0.51% 48
2024
Q1
$598K Hold
6,636
– – 0.47% 48
2023
Q4
$529K Hold
6,636
– – 0.44% 55
2023
Q3
$472K Hold
6,636
– – 0.42% 55
2023
Q2
$511K Hold
6,636
– – 0.42% 55
2023
Q1
$499K Hold
6,636
– – 0.44% 54
2022
Q4
$523K Hold
6,636
– – 0.5% 45
2022
Q3
$466K Hold
6,636
– – 0.47% 49
2022
Q2
$532K Hold
6,636
– – 0.48% 49
2022
Q1
$503K Hold
6,636
– – 0.41% 53
2021
Q4
$566K Hold
6,636
– – 0.45% 51
2021
Q3
$502K Hold
6,636
– – 0.42% 53
2021
Q2
$540K Hold
6,636
– – 0.45% 52
2021
Q1
$523K Hold
6,636
– – 0.46% 52
2020
Q4
$567K Hold
6,636
– – 0.55% 43
2020
Q3
$512K Buy
6,636
+284
+4% +$21.7K 0.56% 44
2020
Q2
$465K Hold
6,352
– – 0.54% 46
2020
Q1
$422K Hold
6,352
– – 0.56% 45
2019
Q4
$437K Hold
6,352
– – 0.44% 54
2019
Q3
$467K Buy
6,352
+600
+10% +$43.5K 0.51% 54
2019
Q2
$412K Hold
5,752
– – 0.46% 54
2019
Q1
$394K Hold
5,752
– – 0.44% 55
2018
Q4
$342K Hold
5,752
– – 0.43% 57
2018
Q3
$385K Hold
5,752
– – 0.42% 55
2018
Q2
$373K Hold
5,752
– – 0.43% 53
2018
Q1
$412K Buy
5,752
+809
+16% +$58.2K 0.49% 49
2017
Q4
$373K Buy
+4,943
New +$361K 0.42% 56
2016
Q3
$366K Sell
4,943
-200
-4% -$14.8K 0.43% 54
2016
Q2
$376K Hold
5,143
– – 0.43% 54
2016
Q1
$363K Buy
5,143
+56
+1% +$3.73K 0.42% 53
2015
Q4
$339K Hold
5,087
– – 0.39% 56
2015
Q3
$323K Hold
5,087
– – 0.43% 51
2015
Q2
$333K Hold
5,087
– – 0.37% 56
2015
Q1
$353K Hold
5,087
– – 0.39% 54
2014
Q4
$352K Buy
+5,087
New +$344K 0.39% 57

Other funds holding CL

Charter Research & Investment Group's CL Position: Q2 2026 in Review

Charter Research & Investment Group held its Colgate-Palmolive (CL) position steady in Q2 2026 at 6,007 shares worth $551K. The position accounts for 0.33% of the portfolio, ranked #59.

Charter Research & Investment Group first reported a position in CL in Q4 2014 and has held it in 43 quarters since. The position peaked at $689K in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Charter Research & Investment Group held 6,007 shares of Colgate-Palmolive worth $551K as of Q2 2026.
  • Charter Research & Investment Group left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.33% of Charter Research & Investment Group's portfolio in Q2 2026, its #59 holding.
  • Charter Research & Investment Group first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 43 quarters since.
  • Charter Research & Investment Group's Colgate-Palmolive position peaked at $689K in Q3 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Charter Research & Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.